Additionally, MAPK1 affects the progression of breast and ovarian cancers by participating in multiple signalling pathways [45, 46], and AKT1 is closely related to cancer and a variety of diseases through its roles in metabolic regulation and signalling pathways [47, 48]. This evidence concerns the gene AKT1 and ovarian carcinoma.